258 related articles for article (PubMed ID: 402006)
1. Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y.
Biddison WE; Palmer JC
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):329-33. PubMed ID: 402006
[TBL] [Abstract][Full Text] [Related]
2. Antigenic changes of DBA/2J mastocytoma cells when grown in the BALB/c mouse.
Wolf JE; Faanes RB; Choi YS
J Natl Cancer Inst; 1977 May; 58(5):1407-12. PubMed ID: 67213
[TBL] [Abstract][Full Text] [Related]
3. Novel tumor-specific antigen(s) response observed in a syngeneic lymphoma-bearing host.
Manson LA
Cancer Detect Prev Suppl; 1987; 1():111-20. PubMed ID: 3121177
[TBL] [Abstract][Full Text] [Related]
4. Allograft cytotoxicity co-operation between alloimmune T cells and macrophages.
Jones B; Jones TC
Immunology; 1978 Feb; 34(2):247-55. PubMed ID: 414994
[TBL] [Abstract][Full Text] [Related]
5. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
Germain RN; Williams RM; Benacerraf B
Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
[TBL] [Abstract][Full Text] [Related]
6. Quantitative studies of the growth and rejection of allogeneic tumour cells in mouse cerebrospinal fluid. Elimination in the absence of H-2 differences.
Doherty PC; Zinkernagel RM
Clin Exp Immunol; 1975 Feb; 19(2):355-66. PubMed ID: 813923
[TBL] [Abstract][Full Text] [Related]
7. Discussion paper: the immune status of the murine host bearing transplantable syngeneic growing tumors.
Manson LA
Ann N Y Acad Sci; 1976; 276():272-5. PubMed ID: 829206
[No Abstract] [Full Text] [Related]
8. Quantitation of the cell-mediated immune response. I. The number of cytolytically active mouse lymphoid cells induced by immunization with allogeneic mastocytoma cells.
Henney CS
J Immunol; 1971 Dec; 107(6):1558-66. PubMed ID: 5000987
[No Abstract] [Full Text] [Related]
9. Allograft cytotoxicity. Two populations of effector cell detectable by cytolytic and cytostatic assays in vitro.
Jones B; Jones TC; Roitt IM
Immunology; 1977 Apr; 32(4):591-9. PubMed ID: 415967
[TBL] [Abstract][Full Text] [Related]
10. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. V. Spleen immunoreactivity and cell mediated cytotoxicity.
Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
Arch Geschwulstforsch; 1987; 57(4):265-74. PubMed ID: 3118852
[TBL] [Abstract][Full Text] [Related]
11. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity.
Herberman RB; Nunn ME; Lavrin DH
Int J Cancer; 1975 Aug; 16(2):216-29. PubMed ID: 50294
[TBL] [Abstract][Full Text] [Related]
12. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
Takei F; Levy JG; Kilburn DG
J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
[TBL] [Abstract][Full Text] [Related]
13. Properties of a subpopulation of T cells bearing histamine receptors.
Plaut M; Lichtenstein LM; Henney CS
J Clin Invest; 1975 Apr; 55(4):856-74. PubMed ID: 164483
[TBL] [Abstract][Full Text] [Related]
14. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
Plata F; Jongeneel V; Cerottini JC; Brunner KT
Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
[TBL] [Abstract][Full Text] [Related]
15. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. IV. Lymph node immunoreactivity and cell-mediated cytotoxicity.
Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
Neoplasma; 1987; 34(4):431-9. PubMed ID: 3116439
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro antitumor activity expressed by cells of concomitantly immune mice.
Tuttle RL; Knick VC; Stopford CR; Wolberg G
Cancer Res; 1983 Jun; 43(6):2600-5. PubMed ID: 6133611
[TBL] [Abstract][Full Text] [Related]
17. Immune responses to mouse neuroblastoma C1300. I. Preliminary observations on cell-mediated immune responses.
Phillips ME; Cipuzak PM; Penta DD; Schachner M
J Natl Cancer Inst; 1977 Oct; 59(4):1215-9. PubMed ID: 903996
[TBL] [Abstract][Full Text] [Related]
18. The genetic control of T cell-mediated immunity against the DBA/2 mastocytoma P-815. II. Low responsiveness in T cell-mediated cytotoxicity accompanied by the inability to produce antibodies in a secondary response.
Kölsch E
Eur J Immunol; 1975 Aug; 5(8):527-32. PubMed ID: 824139
[TBL] [Abstract][Full Text] [Related]
19. Humoral regulation of cell-mediated immunity to syngeneic tumor.
Ting CC
Cancer Res; 1976 Oct; 36(10):3695-701. PubMed ID: 953995
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of cytotoxic T-cell function by virus.
Reinisch CL; Schlossman SF
J Natl Cancer Inst; 1976 Dec; 57(6):1277-81. PubMed ID: 63565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
